glycosylceramide

Term ID

CHEBI:62941

Synonyms

glycosylceramides

Definition

A ceramide compound formed by the replacement of the glycosidic hydroxy group of a cyclic form of a monosaccharide (or derivative) by a ceramide group.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: ceramide glycosphingolipid

ceramide glycosphingolipid Show first 5 Terms
has subtype: (2S,3R,4E,8E)-1-(beta-D-glucopyranosyl)-3-hydroxy-2-[(R)-2′-hydroxyheptadecanoyl]amino-9-methyl-4,8-octadecadiene (3'-sulfo)Galbeta-Cer(d18:0/2-OH-24:1(15Z)) 2-Hydroxy-N-[(4Z,8Z)-3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]hexadecanimidic acid 2-Hydroxy-N-[(4Z,8Z)-3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]pentadecanimidic acid alpha-D-galactosyl-N-(hexacosanoyl)-11,12-methylene-C22-sphinganine ... Show All 60 Terms

(2S,3R,4E,8E)-1-(beta-D-glucopyranosyl)-3-hydroxy-2-[(R)-2′-hydroxyheptadecanoyl]amino-9-methyl-4,8-octadecadiene (3'-sulfo)Galbeta-Cer(d18:0/2-OH-24:1(15Z)) 2-Hydroxy-N-[(4Z,8Z)-3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]hexadecanimidic acid 2-Hydroxy-N-[(4Z,8Z)-3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dien-2-yl]pentadecanimidic acid alpha-D-galactosyl-N-(hexacosanoyl)-11,12-methylene-C22-sphinganine alpha-glucuronosylceramide Alternaroside A Alternaroside C AS 1-1 AS 1-5 Asperiamide A Asperiamide C C8 beta-D-glycosyl N-acylsphingosine Catacerebroside A Cerebroside B cerebroside D Cortenuamide A Cortenuamide B Cortenuamide C Flavicerebroside A Flavicerebroside B Flavuside A Flavuside B Fusaruside Galabiosylceramide (d18:1/16:0) galactosylceramide Galactosylceramide (d18:1/12:0) Galbeta-Cer(d18:1/22:0) Ganglioside GD2 (d18:1/24:0) Ganglioside GM2 (d18:1/26:0) GlcCer(d18:0/18:0(2OH[R])) GlcCer(d18:1(8E)/18:0(2OH[R])) GlcCer(d18:2(4E,8E)/16:0(2OH[R])) GlcCer(d18:2(4E,8E)/18:0(2OH[R])) GlcCer(d18:2(4E,8Z)/17:0(2OH[R])) GlcCer(d18:2(4E,8Z)/25:0(2OH[R])) glucosylceramide glycosyl-N-hexadecanoylsphinganine Lactosylceramide (d18:1/12:0) N-(docosanoyl)-1-(2',3',4',6'-tetraacetylbeta-D-galactosyl)-3-acetylsphingosine N-[(2S,3R,4E)-1-{[(2R,3R,4R,5S,6R)-5-{[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]dodecanimidic acid N-[(4E,8Z)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]hexadecanamide 1-glucoside N-[(4Z)-1-{[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracosanimidic acid Neurosporaside Neurosporaside peracetate oligo[(1->4)-beta-D-glucosyl]-(1<->1)-ceramide oligoglycosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide Phalluside-1 Termitomycesphin A Termitomycesphin B Termitomycesphin C Termitomycesphin D Termitomycesphin E Termitomycesphin F Tetrahexosylceramide (d18:1/26:0) Thraustochytroside A Thraustochytroside B Trihexosylceramide (d18:1/9Z-18:1) Trihexosylceramide (d18:1/12:0) xylosyl-beta-D-ceramide(d18:1(4E)) Show first 5 Terms

Phenotype

Phenotype resulting from glycosylceramide

Phenotype where environments contain glycosylceramide

Phenotype modified by environments containing glycosylceramide

Human Disease Model